Jennifer Doudna and Jonathan Weissman. BARBARA RIES for UCSF
GSK's Barron joins hands with Doudna, Weissman to deploy CRISPR tech in drug discovery
When Hal Barron unveiled his grand plan to turn GlaxoSmithKline’s R&D group around, he championed genetics as one of two key focuses for the UK …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
